0001209191-18-061656.txt : 20181207
0001209191-18-061656.hdr.sgml : 20181207
20181207192356
ACCESSION NUMBER: 0001209191-18-061656
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181206
FILED AS OF DATE: 20181207
DATE AS OF CHANGE: 20181207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANO FRANCIS
CENTRAL INDEX KEY: 0001286710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 181224604
MAIL ADDRESS:
STREET 1: 11 ACORN LANE
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-06
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001286710
CANO FRANCIS
C/O DYNAVAX TECHNOLOGIES CORPORATION
2929 SEVENTH STREET, SUITE 100
BERKELEY
CA
94710
1
0
0
0
Common Stock
2018-12-06
4
S
0
2000
10.471
D
0
D
The shares were sold at prices ranging from $10.47 to $10.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Francis R. Cano, Ph.D., by /s/ Michael Ostrach, Attorney-in Fact
2018-12-07